GlassScriptPhysician profile
Steven Jared Taylor
NPI 1023496734
$876.55
in general payments reported to CMS, 2019-2025
23 companies · $46.03 in 2025
The $46.03 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $96.76 · 2021: $96.62 · 2022: $200 · 2023: $30.39 · 2024: $78.81 · 2025: $46.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $155.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $155.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corcept Therapeutics | $147.30 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $138.63 | 2019-2024 | Breztri |
| Amgen INC. | $74.29 | 2021-2025 | Evenity, Prolia, Prolia |
| Glaxosmithkline, LLC. | $65.49 | 2022-2025 | Trelegy Ellipta |
| Sanofi-Aventis U.S. LLC | $59.59 | 2019-2023 | |
| Abbvie INC. | $33.31 | 2019-2021 | |
| Amarin Pharma, INC. | $31.75 | 2019 | |
| Strongbridge US INC. | $30.80 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $28.18 | 2022 | |
| Exact Sciences Corporation | $28.16 | 2024-2025 | Cologuard Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.01 | 2019 | |
| Astellas Pharma US INC | $25.97 | 2024 | Veozah |
| Alnylam Pharmaceuticals INC. | $25.27 | 2021 | |
| Abbott Laboratories | $24.93 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $21.54 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sunovion Pharmaceuticals INC. | $21.38 | 2021 | |
| Medtronic, INC. | $20.89 | 2024 | Minimed 780g |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.79 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.56 | 2022 | |
| Therapeuticsmd, INC. | $14.07 | 2020 | |
| Merck Sharp & Dohme LLC | $13.69 | 2020 | |
| Lilly USA, LLC | $12.67 | 2022 | |
| Romark Laboratories, Lc | $0.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.